Beyond Chemotherapy and Checkpoint Inhibitors: Weighing the Risks and Benefits of the Novel Therapies for Metastatic Urothelial Carcinoma.
Thomas PowlesDaniel P PetrylakJonathan E RosenbergPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)